21/4877 (0.4%) potential donors tested HIV-1/2 antibody positive. The incidence in the CDC-HR group was 5/561 (0.9%) vs.16/4316 (0.3%) in the Non-CDC HR group (p= 0.15). The incidence of HCV+ tests in the CDC-HR group was 77/561 (13.7%) as compared to 171/4316 (3.5%) in the Non-CDC-HR group (p<.0001). The incidence of HBsAg + tests in the CDC-HR was 0.9% vs. 0.4% in the Non-CDC HR group (p=.18). The incidence of HB ɾ Ab+ tests in the CDC HR group was 66/561 (12%) vs. 243/4316 (5.6%) in the Non-CDC HR group (P<.0001). Summary and Conclusions: There was a trend for higher incidence of positive serology for all tests in the CDC HR group but this was signi¿ cant only for HCV and HB c Ab. The majority of positive cases for each of the tests were in the non High Risk group. These data need further con¿ rmation and should be considered when contemplating routine prospective NAT testing for potential organ donors. Considerations of logistics, cost and potential inadvertent loss of donors and organs associated with prospective NAT testing need to be weighed against the current low incidence of disease transmission.
21/4877 (0.4%) potential donors tested HIV-1/2 antibody positive. The incidence in the CDC-HR group was 5/561 (0.9%) vs.16/4316 (0.3%) in the Non-CDC HR group (p= 0.15). The incidence of HCV+ tests in the CDC-HR group was 77/561 (13.7%) as compared to 171/4316 (3.5%) in the Non-CDC-HR group (p<.0001). The incidence of HBsAg + tests in the CDC-HR was 0.9% vs. 0.4% in the Non-CDC HR group (p=.18). The incidence of HB ɾ Ab+ tests in the CDC HR group was 66/561 (12%) vs. 243/4316 (5.6%) in the Non-CDC HR group (P<.0001). Summary and Conclusions: There was a trend for higher incidence of positive serology for all tests in the CDC HR group but this was signi¿ cant only for HCV and HB c Ab. The majority of positive cases for each of the tests were in the non High Risk group. These data need further con¿ rmation and should be considered when contemplating routine prospective NAT testing for potential organ donors. Considerations of logistics, cost and potential inadvertent loss of donors and organs associated with prospective NAT testing need to be weighed against the current low incidence of disease transmission. Background: IL-6 is a key pro-inÀ ammatory cytokine upregulated after Brain Death (BD) in humans. It leads to adhesion molecule activation and leukocyte invasion in all organs. Pre-explantation organ dysfunction is a direct consequence of inÀ ammation, and renders many organs unsuitable for transplantation. Functionally, IL-6 elevation correlates with deteriorating donor cardiac function in humans and its upregulation in kidney and liver donors worsens ischemia-reperfusion injury in recipients. Corticosteroids modulate gene expression of pro-inÀ ammatory cytokines (including IL-6) thereby ameliorating the inÀ ammatory cascade after BD. Reduced inÀ ammation may help to improve the number of transplantable organs procured from each donor. (The current average is 3.6 organs out of a possible 8 in the United States). Though a bolus dose of Methylprednisolone (Solumedrol) is a component of hormonal resuscitation in hemodynamically unstable BD donors, its plasma half-life is <3 hours and independent of the dose given. Aim: To determine whether Solumedrol given as a continuous infusion suppresses inÀ ammation after BD better than usual care, using IL-6 level as a marker for the degree of inÀ ammation. Methods: Clinical data and serial blood samples were prospectively collected from 11 BD subjects (ages 15-65 years) after obtaining research consent. All patients received a 30mg/kg Solumedrol bolus as a part of usual hormonal resuscitation. Five randomly selected patients also received Solumedrol infusion (100mg/hr) until explantation (experimental SoluDRIP group). while the other 6 served as controls. APACHE II scores (range 12-26) were similar between groups. Plasma IL-6 at baseline; 8, 16 and 24 hours after the Solumedrol bolus and at explantation was quanti¿ ed using IL-6 ELISA (Biogen®) with a lower limit of detection at 4 pg/ml. IL-6 levels were compared between groups at each time point using student t-test with alpha at .05. Revivicor Inc., Blackburg, VA Background: Acute humoral xenograft rejection (AHXR). frequently associated with disseminated intravascular coagulation (DIC). remains a major challenge in pig-to-primate xenotransplantation (Tx). The precise factors initiating graft intravascular thrombosis, particularly when the predominant pathology is thrombotic microangiopathy (TM). remain to be elucidated. Upregulation of donor tissue factor (TF) in the xenograft has been implicated in these processes but the importance of recipient TF has not been addressed. Methods: Organs and aortic patches from Į1,3-galactosyltransferase geneknockout (GTKO) pigs were transplanted into baboons (n=18). with or without immunosuppression. Immunohistochemistry was used to identify IgM, IgG, complement deposition, cellular in¿ ltration, and primate TF expression in the graft. Baboon TF mRNA in the graft was measured by qPCR. Baboon monocytes and platelets were isolated from peripheral blood before and after Tx, and analyzed for TF activity and by À ow cytometry. Functional TF activity was determined by clotting assays after mixing monocytes and platelets with recalci¿ ed Factor VII (FVII) -de¿ cient plasma with or without FVII. Results: In all grafts (with or without immunosuppression). IgM, IgG, and complement deposition was present, with neutrophil and macrophage in¿ ltrates (some cells expressed TF). and intravascular ¿ brin deposition and platelet aggregation characteristic of TM. Clinical and/or laboratory features of DIC occurred in >50% of organ xenograft recipients. Before Tx, monocytes and platelets did not express TF or display TF-dependent procoagulant activity. After pig aortic patch Tx, circulating recipient platelets (but not monocytes) expressed TF and promoted TF-dependent clotting in recalci¿ ed plasma. After pig organ Tx, recipient platelets expressed TF as early as day 3, while monocytes began to express TF later. Furthermore, the organs expressed high
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